English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Tools annual

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Presents the access of premium content as premium feature

Premium Content

Global: Zendy Plus annual

Global: Zendy Free Plan

Patients receiving anticoagulants occasionally suffer from intracranial hemorrhage. Initially, it is important to control the coagulation time for such patients, because of the possible need for emergency surgery. Previously, vitamin K and FFP (fresh frozen plasma) were administered to such patients; however, it took 3 to 6 hours to normalize the PT-INR (Prothrombin Time, International Normalized Ratio), and thus the bleeding could increase and the patients’ condition might then become critical. To correct the coagulation time quickly and evacuate the hematoma as soon as possible, ninth factor complex (PPSB-HT) was administered to 5 patients who had taken Warfarin and suffered from intracranial hemorrhage. In all patients, the PT-INR quickly normalized within 10 to 20 minutes, and they were thereafter successfully treated surgically. The administration of PPSB-HT is critical to correct the coagulation time in patients taking Warfarin and requiring emergency surgery.

How to Manage the Patients Receiving the Anticoagulant Associated with Intracranial Hemorrhage